Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000232446 | SCV000289594 | benign | Intellectual disability, autosomal dominant 5 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317766 | SCV000850090 | likely benign | Inborn genetic diseases | 2016-07-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV001289211 | SCV001476874 | benign | not specified | 2020-02-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001532541 | SCV001748152 | benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | SYNGAP1: BP4, BP7, BS1, BS2 |
Gene |
RCV001532541 | SCV001915904 | benign | not provided | 2018-08-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000232446 | SCV002805163 | likely benign | Intellectual disability, autosomal dominant 5 | 2021-08-31 | criteria provided, single submitter | clinical testing |